PASG

Passage BIO, Inc. PASG

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 29 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$6.82M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PASG

Earnings Per Share

13fpro.ai/company/PASG

Loading ratio trend…

PASG insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Passage BIO, Inc. (PASG): stock profile, AI score and financials

Passage BIO, Inc. (PASG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. PASG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 29 institutional filers currently hold this stock. Top institutional holders of PASG by reported 13-F value include Lynx1 Capital Management, VANGUARD CAPITAL MANAGEMENT, BALYASNY ASSET MANAGEMENT L.P., based on the most recent SEC filings. PASG trades on the Nasdaq exchange and files with the SEC under CIK 1787297. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PASG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Passage BIO, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1787297 →